VINCERX PHARMA
We derive our name from the latin word vincēre meaning
“to conquer”.
We aspire to conquer cancer with innovative therapies.

Our Vision

To address the unmet medical needs of our patients with paradigm-shifting therapeutics.

Clinical
Program

VIP152 inhibits PTEFb phosphorylation of RNA polymerase II (RNAPII), thereby preventing transcription elongation and blocking expression of genes that drive cancer.

Pipeline

VINCERX PHARMA
NEWS

Vincerx Pharma Announces Completion of Public Warrant Redemption

PALO ALTO, Calif. , May 06, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) (the “Company”), today announced the completion of its redemption event with respect to its outstanding public warrants (the “Public Warrants”). The Company issued a press release on April 5, 2021 , stating

Menu